BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belenkaia LV, Lazareva LM, Walker W, Lizneva DV, Suturina LV. Criteria, phenotypes and prevalence of polycystic ovary syndrome. Minerva Ginecol 2019;71:211-23. [PMID: 31089072 DOI: 10.23736/S0026-4784.19.04404-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Yang C, Xie H, Liu Y, Liao Y. Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome. Int J Endocrinol 2021;2021:5561980. [PMID: 34422044 DOI: 10.1155/2021/5561980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Liu MM, Wang C, Zhang YH, Wang RJ, Lu XM, Li PL, Wang YX, Gong PD, Liu N, Zhang T, Tian TT. Potential of thrombospondin-1 in treatment of polycystic ovary syndrome rat model: a preliminary study. Gynecol Endocrinol 2021;37:1020-6. [PMID: 34282706 DOI: 10.1080/09513590.2021.1950682] [Reference Citation Analysis]
3 Zhou S, Ji Y, Wang H. The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis. BMC Pregnancy Childbirth 2021;21:336. [PMID: 33906610 DOI: 10.1186/s12884-021-03808-3] [Reference Citation Analysis]
4 Juliawan IMP, Suwana FP, Annas JY, Akbar MF, Widjiati W. High Sucrose and Cholic Acid Diet Triggers PCOS-like Phenotype and Reduces Enterobacteriaceae Colonies in Female Wistar Rats. Pathophysiology 2022;29:344-53. [PMID: 35893596 DOI: 10.3390/pathophysiology29030026] [Reference Citation Analysis]
5 Mukhopadhyay R, Prabhu NB, Kabekkodu SP, Rai PS. Review on bisphenol A and the risk of polycystic ovarian syndrome: an insight from endocrine and gene expression. Environ Sci Pollut Res Int 2022;29:32631-50. [PMID: 35199272 DOI: 10.1007/s11356-022-19244-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Di Bari F, Catalano A, Bellone F, Martino G, Benvenga S. Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome. Metabolites 2021;11:116. [PMID: 33670644 DOI: 10.3390/metabo11020116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Devarbhavi P, Telang L, Vastrad B, Tengli A, Vastrad C, Kotturshetti I. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules. Reprod Biol Endocrinol 2021;19:31. [PMID: 33622336 DOI: 10.1186/s12958-021-00706-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sharma M, Barai RS, Kundu I, Bhaye S, Pokar K, Idicula-Thomas S. PCOSKBR2: a database of genes, diseases, pathways, and networks associated with polycystic ovary syndrome. Sci Rep 2020;10:14738. [PMID: 32895427 DOI: 10.1038/s41598-020-71418-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Li L, Huang N, Qi Y, Li Y, Wang L. Effect of Wenshentiaojing Decoction on Hormone Level and Follicular Number in Patients with Menstrual Disorder of Polycystic Ovary Syndrome. Evid Based Complement Alternat Med 2021;2021:4975867. [PMID: 34880919 DOI: 10.1155/2021/4975867] [Reference Citation Analysis]
10 Zhang Z, Huang L, Brayboy L. Macrophages: an indispensable piece of ovarian health. Biol Reprod 2021;104:527-38. [PMID: 33274732 DOI: 10.1093/biolre/ioaa219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Dabravolski SA, Nikiforov NG, Eid AH, Nedosugova LV, Starodubova AV, Popkova TV, Bezsonov EE, Orekhov AN. Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome. Int J Mol Sci 2021;22:3923. [PMID: 33920227 DOI: 10.3390/ijms22083923] [Reference Citation Analysis]
12 Sheng C, Zhang J, Jue J, Xi X. The Relationship between Ovarian Ultrasound Parameters and Endocrine and Metabolic Indicators in Patients with Ovarian Syndrome. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-6. [DOI: 10.1155/2022/7238344] [Reference Citation Analysis]
13 Jiang S, Tang T, Sheng Y, Li R, Xu H. The Effects of Letrozole and Metformin Combined with Targeted Nursing Care on Ovarian Function, LH, and FSH in Infertile Patients with Polycystic Ovary Syndrome. J Healthc Eng 2022;2022:3712166. [PMID: 35368950 DOI: 10.1155/2022/3712166] [Reference Citation Analysis]
14 Huang L, Liang A, Li T, Lei X, Chen X, Liao B, Tang J, Cao X, Chen G, Chen F, Wang Y, Hu L, He W, Li M. Mogroside V Improves Follicular Development and Ovulation in Young-Adult PCOS Rats Induced by Letrozole and High-Fat Diet Through Promoting Glycolysis. Front Endocrinol 2022;13:838204. [DOI: 10.3389/fendo.2022.838204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhou S, Lu D, Wen S, Sheng Y, Kang D, Xu L. Elevated Anti-Müllerian Hormone Levels in Newborns of Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis Based on Observational Studies. Reprod Sci 2021. [PMID: 34129217 DOI: 10.1007/s43032-021-00652-w] [Reference Citation Analysis]
16 Karamali M, Gholizadeh M. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome. Gynecol Endocrinol 2021;:1-5. [PMID: 34664527 DOI: 10.1080/09513590.2021.1991910] [Reference Citation Analysis]
17 Kazemi M, Lalooha F, Nooshabadi MR, Dashti F, Kavianpour M, Haghighian HK. Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome. J Ovarian Res 2021;14:100. [PMID: 34330312 DOI: 10.1186/s13048-021-00849-2] [Reference Citation Analysis]
18 Liang A, Huang L, Liu H, He W, Lei X, Li M, Li S, Liang H, Chen G, Tang J, Chen F, Cao X, Wang Y, Shen X, Chen X. Resveratrol Improves Follicular Development of PCOS Rats by Regulating the Glycolytic Pathway. Mol Nutr Food Res 2021;:e2100457. [PMID: 34664388 DOI: 10.1002/mnfr.202100457] [Reference Citation Analysis]
19 Capuzzo M, Donno V, LA Marca A. Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone. Minerva Endocrinol 2020;45:376-80. [PMID: 33478206 DOI: 10.23736/S0391-1977.20.03390-8] [Reference Citation Analysis]
20 Lu L, Li X, Lv L, Xu Y, Wu B, Huang C. Dietary and serum n-3 PUFA and polycystic ovary syndrome: a matched case-control study. Br J Nutr 2021;:1-10. [PMID: 34372961 DOI: 10.1017/S0007114521003007] [Reference Citation Analysis]
21 Kolesnikova LI, Krusko OV, Belenkaya LV, Sholokhov LF, Grebenkina LA, Kurashova NA, Kolesnikov SI. Changes in the Lipid Peroxidation-Antioxidant Protection System in Women with Ovarian Hyperandrogenism at Different Periods of Reproductive Age. Bull Exp Biol Med 2021;170:308-11. [PMID: 33452976 DOI: 10.1007/s10517-021-05057-y] [Reference Citation Analysis]